132 related articles for article (PubMed ID: 6291801)
1. Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure.
Kugler J; Maskin C; Frishman WH; Sonnenblick EH; LeJemtel TH
Circulation; 1982 Dec; 66(6):1256-61. PubMed ID: 6291801
[TBL] [Abstract][Full Text] [Related]
2. Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure.
Maskin CS; Forman R; Sonnenblick EH; Frishman WH; LeJemtel TH
Am J Cardiol; 1983 Jan; 51(1):177-82. PubMed ID: 6849256
[TBL] [Abstract][Full Text] [Related]
3. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Topic N; Kramer B; Massie B
Am Heart J; 1982 Nov; 104(5 Pt 2):1172-9. PubMed ID: 6291362
[TBL] [Abstract][Full Text] [Related]
4. Acute inotropic stimulation with dopamine in severe congestive heart failure: beneficial hemodynamic effect at rest but not during maximal exercise.
Maskin CS; Kugler J; Sonnenblick EH; LeJemtel TH
Am J Cardiol; 1983 Nov; 52(8):1028-32. PubMed ID: 6637818
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic response to converting enzyme inhibition at rest and exercise in humans.
Fagard R; Lijnen P; Vanhees L; Amery A
J Appl Physiol Respir Environ Exerc Physiol; 1982 Sep; 53(3):576-81. PubMed ID: 6290435
[TBL] [Abstract][Full Text] [Related]
6. Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle.
Timmis AD; Bojanowski LM; Najm YC; Nelson DJ; Gosling RG
Eur Heart J; 1987 Dec; 8(12):1295-304. PubMed ID: 3325289
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Awan NA; Evenson MK; Needham KE; Win A; Mason DT
Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
9. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.
Banaszewski M; Rydlewska-Sadowska W; Rubkiewicz S
J Heart Valve Dis; 1998 Sep; 7(5):488-99. PubMed ID: 9793844
[TBL] [Abstract][Full Text] [Related]
10. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
11. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure.
Sullivan MJ; Knight JD; Higginbotham MB; Cobb FR
Circulation; 1989 Oct; 80(4):769-81. PubMed ID: 2791242
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and chronic alacepril treatment on exercise capacity and hemodynamics in patients with heart failure: a preliminary study.
Osaki S; Kinugawa T; Ogino K; Kato M; Furuse Y; Tomikura Y; Igawa O; Hisatome ; Shigemasa C
Int J Clin Pharmacol Ther; 2002 Feb; 40(2):69-74. PubMed ID: 11862975
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
[TBL] [Abstract][Full Text] [Related]
14. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure.
Mancini DM; Davis L; Wexler JP; Chadwick B; LeJemtel TH
J Am Coll Cardiol; 1987 Oct; 10(4):845-50. PubMed ID: 3309004
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M
J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
[TBL] [Abstract][Full Text] [Related]
16. Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure.
Imaizumi T; Takeshita A; Nakamura N; Sakai K; Hirooka Y; Suzuki S; Yoshida M; Nakamura M
Jpn Heart J; 1990 Nov; 31(6):817-28. PubMed ID: 2084278
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of captopril in patients with severe chronic heart failure.
LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic minoxidil administration on rest and exercise hemodynamics and clinical status in patients with severe, chronic heart failure.
Nathan M; Rubin SA; Siemienczuk D; Swan HJ
Am J Cardiol; 1982 Nov; 50(5):960-6. PubMed ID: 7137047
[TBL] [Abstract][Full Text] [Related]
19. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
[TBL] [Abstract][Full Text] [Related]
20. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
